Cite
HARVARD Citation
Wright, K. et al. (2021). Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?. Evidence-based practice. 24 (11), pp. 35-36. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wright, K. et al. (2021). Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?. Evidence-based practice. 24 (11), pp. 35-36. [Online].